Breathing Disorders Treatment Market Highlights:
The breathing disorders treatment market is growing pervasively over the past few years. The market is getting a boost from the rising prevalence of various diseases disorders related to respiratory tracts, such as COPD, asthma, allergic rhinitis, pulmonary hypertension, cystic fibrosis, IPF, and others. Moreover, increasing occurrences of lung diseases alongside the increasing geriatric population accelerates the market on a global level.
According to Market Research Future (MRFR), a leading research firm, the global Breathing Disorders Treatment Market Size may experience impressive growth by 2030. MRFR, in its recent study report, also asserts that the market would register a 7.5% CAGR during the review period (2023 – 2030). Augmenting demand for minimally invasive procedures for diagnosing treatment supports the market growth.
Recent technological advancements are fostering market growth, offering phenomenally benefitting results, and improving the quality of life patients. Additionally, the increasing market demand led by the rising inclination of medical professionals is anticipated to boost the market growth, widening the adoption of drugs for treatments. Many emerging treatments and techniques are predicted to increase the size of the market.
Conversely, stringent government regulation related to steroid content, which leads to side effects and allergic reactions can hinder the market growth during the forecasted period. Also, unmet clinical needs in emerging regions are likely to pose challenges to the growth of the market. Nevertheless, growing advances in medical technology would support the market growth bringing about new techniques that can evolve treatments more effectively efficiently.
Breathing Disorders Treatment Market - Competitive Analysis
Highly competitive, the global breathing disorders treatment market appears fragmented due to the presence of several well-established players. To gain a significant market share, players incorporate strategic initiatives like mergers acquisitions, collaborations, expansion, and new therapeutics technology launch. They invest heavily in RD and clinical trials to develop effective drugs.
Major Players:
Players leading the breathing disorders treatment market include AstraZeneca, GlaxoSmithKline, Merck Sharp Dohme Corp., Abbott, Medtronic plc., Hoffmann-La Roche Ltd., Novartis AG, Reddy’s Laboratories, Amgen, Aurobindo Pharma, Bayer AG, and Biogen, among others.
Industry/Innovation/ Related News:
July 25, 2023 ---- Zambon S.p.A. (Italy), a multinational pharmaceutical company, announced the acquisition of Breath Therapeutics and its subsidiaries (Germany), a leading drug formulation and manufacturing company operating in Europe and the US. The acquisition would extend Zambon’s presence in severe respiratory diseases across Europe and the US.
It reinforces the company’s strategy to grow through further globalization and continued investment in Specialty Care. Breath Therapeutics is currently developing an innovative inhalation therapy for Bronchiolitis Obliterans Syndrome (BOS), a rare fatal respiratory disease. The therapeutics are in phase III.
Breathing Disorders Treatment Market - Segments
The report has been segmented into four dynamics to widen the scope of understanding,
By Drug Type : Antibiotics, Non-Steroidal Anti-Inflammatory Drug (NSAIDS), Cough Suppressant, Nasal Decongestant, and others.
By Indication : Asthma, Chronic Obstructive Pulmonary Disease (COPD), Allergic Rhinitis, Pulmonary Hypertension, Cystic Fibrosis (CF), Idiopathic Pulmonary Fibrosis, and others.
By End-user : Hospital Clinics, Retail Pharmacies, Online Pharmacies, and others.
By Regions : Europe, North America, APAC, and the Rest-of-the-World (RoW).
Global Breathing Disorders Treatment Market - Regional Analysis
North America would continue dominating the global breathing disorders treatment market. The increasing prevalence of respiratory disorders and heart-related problems, alongside the rising geriatric population, drive the growth of the regional market. Breathing disorders treatment market in the US heads the regional market with the high occurrences of various pulmonary disorders and diseases.
Besides, the high prevalence of diseases such as cystic fibrosis in the US and Canada is expected to foster regional market growth. Furthermore, high healthcare expenditure and the high adoption of advanced technology drive the breathing disorders treatment market in North America.
Breathing disorders treatment market in the European region is expected to grow considerably over the forecast period. Factors such as the increasing health problems such as hypertension, stress, obesity, and changing lifestyles among the population drive the market demand hugely. Environmental changes are also contributing to regional market growth.
The presence of a well-established healthcare system and the involvement of key companies in the region are factors influencing the market. Additionally, increasing funding for research by private public organizations would boost the growth of the breathing disorders market in this region.
The Asia Pacific breathing disorders treatment market is expected to register a substantial CAGR during the forecast period. The increasing patient population and government initiatives for healthcare reforms are driving the growth of the breathing disorders treatment market in the APAC region. Countries such as Japan, Hong Kong, and Singapore, significantly contribute to the regional market growth heading with the high prevalence of asthma. Also, the rising demand for pharmaceutical products required for the treatment of chronic obstructive pulmonary disease (COPD), asthma, and other breathing-related disorders would support market growth.
About US:
Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013v
